| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| BEAM | 37.82% | $2.22B | -14.88% | 0.00% |
| RGNX | 37.33% | $456.52M | -28.72% | 0.00% |
| DNLI | 35.45% | $2.23B | -33.52% | 0.00% |
| CRSP | 34.69% | $5.10B | +3.85% | 0.00% |
| NTLA | 34.66% | $1.26B | -50.63% | 0.00% |
| ARWR | 34.43% | $2.60B | -33.24% | 0.00% |
| BNT | 33.51% | $12.84B | +42.16% | 0.00% |
| RY | 33.46% | $187.98B | +20.88% | 3.12% |
| SYRE | 33.39% | $963.24M | -43.26% | 0.00% |
| ABCL | 33.38% | $1.27B | +35.78% | 0.00% |
| BN | 32.87% | $105.41B | +42.26% | 0.54% |
| MOV | 32.73% | $373.80M | -34.18% | 8.26% |
| MCY | 32.70% | $3.67B | +22.99% | 1.93% |
| ARW | 32.33% | $6.91B | +9.19% | 0.00% |
| OEC | 32.32% | $636.97M | -49.10% | 0.74% |
| CMPS | 32.05% | $345.40M | -48.48% | 0.00% |
| APTV | 31.97% | $15.37B | -1.63% | 0.00% |
| GMAB | 31.91% | $13.45B | -16.69% | 0.00% |
| TWST | 31.37% | $2.30B | -26.70% | 0.00% |
| IVR | 31.21% | $511.71M | -18.06% | 19.17% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ATEC | -10.90% | $1.69B | +5.66% | 0.00% |
| UNH | -10.42% | $271.70B | -40.62% | 2.85% |
| ELV | -9.33% | $78.14B | -35.21% | 1.95% |
| CNC | -9.03% | $16.18B | -51.64% | 0.00% |
| MOH | -8.39% | $12.39B | -21.20% | 0.00% |
| ROOT | -8.22% | $1.96B | +92.18% | 0.00% |
| ALHC | -8.12% | $2.65B | +51.87% | 0.00% |
| PDD | -8.07% | $145.78B | -24.61% | 0.00% |
| DFDV | -7.56% | $363.21M | +2,422.23% | 0.00% |
| UUU | -6.59% | $8.22M | +134.65% | 0.00% |
| K | -6.03% | $27.64B | +40.17% | 2.86% |
| XGN | -5.76% | $153.02M | +261.76% | 0.00% |
| HUSA | -5.01% | $20.99M | -8.33% | 0.00% |
| PPC | -4.83% | $10.64B | +33.60% | 0.00% |
| CACI | -4.61% | $10.55B | +10.56% | 0.00% |
| MO | -4.48% | $98.62B | +24.36% | 7.00% |
| DUK | -4.41% | $91.85B | +13.12% | 3.57% |
| AQB | -4.32% | $3.04M | -56.34% | 0.00% |
| CEG | -3.98% | $98.29B | +44.63% | 0.48% |
| ED | -3.98% | $36.42B | +10.51% | 3.36% |
Current Value
$30.491 Year Return
Current Value
$30.491 Year Return
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| SCHZ | -0.04% | $8.54B | 0.03% |
| SCMB | -0.07% | $2.10B | 0.03% |
| EAGG | -0.07% | $3.96B | 0.1% |
| BKAG | 0.08% | $1.91B | 0% |
| STIP | -0.16% | $12.68B | 0.03% |
| FIXD | -0.17% | $3.39B | 0.65% |
| MUST | -0.23% | $439.44M | 0.23% |
| BLV | 0.23% | $5.58B | 0.03% |
| HTAB | 0.23% | $410.25M | 0.39% |
| BNDW | -0.23% | $1.28B | 0.05% |
| VTIP | -0.25% | $15.15B | 0.03% |
| SHYM | -0.26% | $355.86M | 0.35% |
| STPZ | 0.31% | $443.27M | 0.2% |
| GSY | -0.31% | $2.73B | 0.22% |
| MLN | 0.36% | $513.19M | 0.24% |
| GCOR | -0.40% | $588.82M | 0.08% |
| SPAB | -0.40% | $8.76B | 0.03% |
| VCRB | -0.43% | $3.20B | 0.1% |
| XHLF | -0.45% | $1.73B | 0.03% |
| FLCB | 0.48% | $2.65B | 0.15% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -28.05% | $184.73M | 0.85% |
| TAIL | -25.82% | $94.86M | 0.59% |
| BTAL | -24.09% | $315.93M | 1.43% |
| TBLL | -19.01% | $2.12B | 0.08% |
| XONE | -17.34% | $628.85M | 0.03% |
| GBIL | -12.73% | $6.36B | 0.12% |
| USDU | -10.73% | $129.80M | 0.5% |
| SCHO | -10.63% | $10.98B | 0.03% |
| UTWO | -10.36% | $376.33M | 0.15% |
| VGSH | -9.97% | $22.68B | 0.03% |
| SHV | -9.55% | $20.59B | 0.15% |
| BILZ | -9.37% | $851.85M | 0.14% |
| IBTG | -9.24% | $1.92B | 0.07% |
| BILS | -9.06% | $3.80B | 0.1356% |
| UUP | -8.98% | $196.45M | 0.77% |
| SHY | -8.96% | $23.54B | 0.15% |
| SPTS | -8.80% | $5.77B | 0.03% |
| IBTF | -8.40% | $1.98B | 0.07% |
| CLIP | -8.24% | $1.55B | 0.07% |
| IBTH | -7.99% | $1.62B | 0.07% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GNOM | 39.41% | $46.47M | 0.5% |
| ARKG | 36.38% | $1.03B | 0.75% |
| IDHQ | 35.29% | $463.91M | 0.29% |
| FNDC | 35.24% | $2.94B | 0.39% |
| SPDW | 35.18% | $26.93B | 0.03% |
| QAI | 35.17% | $708.69M | 0.91% |
| IEV | 35.10% | $2.30B | 0.61% |
| VIGI | 34.99% | $8.33B | 0.1% |
| PID | 34.95% | $854.03M | 0.53% |
| DFAI | 34.92% | $10.48B | 0.18% |
| XBI | 34.85% | $4.81B | 0.35% |
| SPEU | 34.83% | $693.33M | 0.07% |
| VEA | 34.83% | $164.08B | 0.03% |
| VSS | 34.77% | $9.32B | 0.07% |
| IWC | 34.75% | $840.86M | 0.6% |
| SCHC | 34.72% | $4.58B | 0.08% |
| VSGX | 34.71% | $4.76B | 0.1% |
| DFIC | 34.71% | $9.65B | 0.23% |
| SCHF | 34.64% | $48.66B | 0.03% |
| IDEV | 34.58% | $20.31B | 0.04% |
Yahoo
Former Horizon CFO joins Galapagos with deep expertise in international corporate finance, M&A, business development and strategic leadership Mechelen, Belgium; June 23, 2025, 07:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG) today announced the appointment of Mr. Aaron Cox as Chief Financial Officer, effective July 7, 2025. Mr. Cox succeeds Mr. Thad Huston, who will remain with the company through July 31, 2025, to ensure a smooth transition of respo
SeekingAlpha
Greenlight Capital outperforms with an 8.2% Q1 2025 return. Check out the major stake increases and selective trims in the portfolio.
Yahoo
Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase 1/2 study, 32 received GLPG5101; 94% were infused with fresh CAR-T cells, and 93% were treated within seven days of manufacturing GLPG5101 demonstrated promising efficacy with durable CAR-T cell persistence and a favorable safety profile, including a 97% complete response rate, 100% MRD negativity in evaluable patients, sustained CAR-T expansion up to 21 months, and low rates of severe CRS and ICANS, with no deaths reported Mechelen
Yahoo
Key Insights Given the large stake in the stock by institutions, Galapagos' stock price might be vulnerable to their...
Yahoo
Data reported from the ongoing ATALANTA-1 Phase 1/2 study in a heavily pretreated relapsed refractory non-Hodgkin’s Lymphoma (R/R NHL) patient population demonstrate low rates of high-grade toxicities Of the 64 patients enrolled, 61 received treatment, resulting in a 5% attrition rate, significantly lower than industry benchmarks. 95% of patients were infused with fresh, stem-like early memory CD19 CAR-T cells, with 89% receiving treatment within 7 days, avoiding the need for cryopreservation an
Yahoo
Mechelen, Belgium; May 27, 2025, 22:30 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 925,000 subscription rights under a new subscription right plan. On May 27, 2025, the Board of Directors of Galapagos approved “Subscription Right Plan 2025 (A)”, intended for personnel of the Company, within the framework of the authorized capital. Under this subscription right plan, 925,000 subscription rights were created, subject to ac
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TMUS | 0.04% | $259.05B | +27.59% | 1.44% |
| DVA | -0.05% | $10.83B | +2.29% | 0.00% |
| CATO | -0.06% | $60.00M | -43.60% | 5.59% |
| AEP | -0.10% | $56.65B | +16.73% | 3.49% |
| FLUX | -0.16% | $35.49M | -48.03% | 0.00% |
| RBLX | -0.19% | $71.24B | +172.66% | 0.00% |
| ODP | -0.21% | $558.63M | -52.43% | 0.00% |
| TGI | -0.23% | $2.01B | +59.69% | 0.00% |
| BE | -0.25% | $6.00B | +93.34% | 0.00% |
| LDOS | 0.28% | $20.98B | +9.43% | 0.97% |
| HSY | -0.31% | $33.36B | -11.86% | 3.35% |
| VSTA | 0.31% | $325.62M | +30.97% | 0.00% |
| VSA | -0.33% | $8.59M | -17.17% | 0.00% |
| AMT | -0.37% | $103.46B | +6.67% | 3.01% |
| CHRS | 0.40% | $100.54M | -46.14% | 0.00% |
| IMDX | 0.43% | $82.65M | -8.25% | 0.00% |
| TK | -0.47% | $650.10M | +23.51% | 0.00% |
| NEUE | 0.47% | $60.71M | +34.39% | 0.00% |
| CALM | 0.48% | $5.37B | +59.42% | 6.69% |
| LMT | 0.50% | $108.79B | +0.85% | 2.81% |
